Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations

Tenofovir, currently marketed as the prodrug tenofovir disoproxil fumarate, is used clinically to treat patients with HIV/AIDS. The oral bioavailability of tenofovir is relatively low, limiting its clinical effectiveness. Encapsulation of tenofovir within modified long-circulating liposomes would de...

Full description

Saved in:
Bibliographic Details
Published in:Clin Pharmacol
Main Authors: Spinks, Crystal B, Zidan, Ahmed S, Khan, Mansoor A, Habib, Muhammad J, Faustino, Patrick J
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2017
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5327912/
https://ncbi.nlm.nih.gov/pubmed/28260952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S119875
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items